Novel nanostructured biomaterials: Implications for coronary stent thrombosis

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 6063-6076

  Karagkiozaki, Varvara ^a   Karagiannidis, Panagiotis G ^a   Kalfagiannis, Nikolaos ^a   Kavatzikidou, Paraskevi ^a   Patsalas, Panagiotis ^b   Georgiou, Despoina ^a   Logothetidis, Stergios ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Atomic force microscopy; Carbon nanotubes; Cell viability; Platelets; Titanium boron nitride

Indexed keywords

CARBON NANOTUBE; NANOMATERIAL; STAINLESS STEEL; TITANIUM BORON NITRIDE; TITANIUM DERIVATIVE; TITANIUM DIBORIDE; UNCLASSIFIED DRUG; BIOMATERIAL; NANOPARTICLE;

ANIMAL CELL; ARTICLE; ATOMIC FORCE MICROSCOPY; BIOCOMPATIBILITY; BIOSAFETY; CELL VIABILITY; CONTROLLED STUDY; CORONARY STENT; CYTOTOXICITY TEST; HYDROPHILICITY; MATERIAL COATING; MOUSE; NANOBIOTECHNOLOGY; NANOFABRICATION; NONHUMAN; PHYSICAL CHEMISTRY; SCANNING ELECTRON MICROSCOPY; STENT THROMBOSIS; STOICHIOMETRY; THROMBOCYTE ADHESION; THROMBOGENICITY; WETTABILITY; CELL CULTURE; COMPARATIVE STUDY; CORONARY ARTERY THROMBOSIS; DRUG EFFECT; HUMAN; MATERIALS TESTING; STENT; SURFACE PROPERTY; THROMBOCYTE;

BIOCOMPATIBLE MATERIALS; BLOOD PLATELETS; CELLS, CULTURED; CORONARY THROMBOSIS; HUMANS; MATERIALS TESTING; NANOPARTICLES; PLATELET ADHESIVENESS; STENTS; SURFACE PROPERTIES;

EID: 84875861368     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S34320     Document Type: Article

References (45)

1. Colombo A, lakovou I. Drug-eluting stents: the new gold standard for percutaneous coronary revascularisation. Eur Heart J. 2004;25(11): 895-897.
2. Smith EJ, Jain KA, Rothman MT. New developments in coronary stent technology. JInterv Cardiol. 2006;19(6):493-499.
3. Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med. 2007;356(10):998-1008.
4. Bavry AA, Kumbhani DJ, Helton TJ, Borek PP, Mood GR, Bhatt DL. Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials. Am JMed. 2006;119(12):1056-1061.
5. Hara H, Nakamura M, Palmaz JC, Schwartz RS. Role of stent design and coatings on restenosis and thrombosis. Adv Drug Deliv Rev. 2006;58(3):377-386.
6. Zhang L, Webster TJ. Nanotechnology and nanomaterials: promises for improved tissue regeneration. Nano Today. 2009;4(1):66-80.
7. Nakano K, Egashira K, Masuda S, et al. Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology: efficient nano-drug delivery via bioabsorbable polymeric nanoparticle-eluting stents in porcine coronary arteries. JACC Cardiovasc Interv. 2009;2(4):277-283.
8. Logothetidis S. Haemocompatibility of carbon based thin films. Diam Relat Mater. 2007;16(10):1847-1857.
9. Karagkiozaki VC, Logothetidis SD, Kassavetis SN, Giannoglou GD. Nanomedicine for the reduction of the thrombogenicity of stent coatings. Int J Nanomedicine. 2010;5:239-248.
10. Lousinian S, Logothetidis S, Laskarakis A, Gioti M. Haemocompatibility of amorphous hydrogenated carbon thin films, optical properties and adsorption mechanisms of blood plasma proteins. Biomol Eng. 2007;24(1):107-112.
11. García-González L, Hernández-Torres J, García-Ramírez PJ, et al. Structure and mechanical properties of TiBN coatings fabricated by dc reactive sputtering technique. JMater Process Technol. 2007;186(1-3): 362-366.
12. Yang Z, Zhang Y, Yang Y, et al. Pharmacological and toxicological target organelles and safe use of single-walled carbon nanotubes as drug carriers in treating Alzheimer disease. Nanomedicine. 2010;6(3): 427-441.
13. Ménard-Moyon C, Kostarelos K, Prato M, Bianco A. Functionalized carbon nanotubes for probing and modulating molecular functions. JChem Biol. 2010;17(2):107-115.
14. Logothetidis S, Gioti M, Lousinian S, Fotiadou S. Haemocompatibility studies on carbon-based thin films by ellipsometry. Thin Solid Films. 2005;482(1-2):126-132.
15. Chibowski E, Perea-Carpio R. Problems of contact angle and solid surface free energy determination. Adv Colloid Interface Sci. 2002;98(2): 245-264.
16. Müller DJ, Anderson K. Biomolecular imaging using atomic force microscopy. Trends Biotechnol. 2002;20(8):S45-S49.
17. Allison DP, Mortensen NP, Sullivan CJ, Doktycz MJ. Atomic force microscopy of biological samples. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010;2(6):618-634.
18. Karagkiozaki V, Logothetidis S, Kalfagiannis N, Lousinian S, Giannoglou G. Atomic force microscopy probing platelet activation behavior on titanium nitride nanocoatings for biomedical applications. Nanomedicine. 2009;5(1):64-72.
19. Hartwig JH. Platelet structure. In: Michelson AD, editor. Platelets. San Diego, CA: Academic Press; 2002:37-45.
20. Karagkiozaki V, Logothetidis S, Giannoglou G. Advances in stent coating technology via nanotechnology tools and process. Eur J Nanomed. 2008;1(1):24-28.
21. Karagkiozaki V, Logothetidis S, Kassavetis S, Lousinian S. Nanoscale characterization of biological and mechanical profile of carbon stent nanocoatings. Eur J Nanomed. 2009;2(1):14-21.
22. Karagkiozaki V, Logothetidis S, Laskarakis A, Giannoglou G, Lousinian S. AFM study of the thrombogenicity of carbon-based coatings for cardiovascular applications. Mater Sci Eng B. 2008;152(1-3): 16-21.
23. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48(1):193-202.
24. O'Brien B, Carroll W. The evolution of cardiovascular stent materials and surfaces in response to clinical drivers: a review. Acta Biomater. 2009;5(4):945-958.
25. Choudhary S, Berhe M, Haberstroh KM, Webster TJ. Increased endothelial and vascular smooth muscle cell adhesion on nanostructured titanium and CoCrMo. Int JNanomed. 2006;1(1):41-49.
26. Maguire PD, McLaughlin JA, Okpalugo TI, et al. Mechanical stability, corrosion performance and bioresponse of amorphous diamondlike carbon for medical stents and guidewires. Diam Relat Mater. 2005;14(8):1277-1288.
27. Mitsakakis K, Lousinian S, Logothetidis S. Early stages of human plasma proteins adsorption probed by Atomic Force Microscope. Biomol Eng. 2007;24(1):119-124.
28. Lord MS, Foss M, Besenbacher F. Influence of nanoscale surface topography on protein adsorption and cellular response. Nano Today. 2010;5(1):66-78.
29. Anselme K, Davidson P, Popa AM, Giazzon M, Liley M, Ploux L. The interaction of cells and bacteria with surfaces structured at the nanometre scale. Acta Biomater. 2010;6(10):824-846.
30. Yang P, Huang N, Leng YX, et al. Activation of platelets adhered on amorphous hydrogenated carbon (a-C:H) films synthesized by plasma immersion ion implantation-deposition (PIII-D). Biomaterials. 2003;24(17):2821-2829.
31. Karagkiozaki V, Logothetidis S, Lousinian S, Giannoglou G. Impact of surface electric properties of carbon-based thin films on platelets activation for nano-medical and nano-sensing applications. Int J Nanomed. 2008;3(4):461-469.
32. Holzschuh H. Deposition of Ti-B-N (single and multilayer) and Zr-B-N coatings by chemical vapor deposition techniques on cutting tools. Thin Solid Films. 2004;469-470:92-98.
33. Aouadi SM, Debessai M, Namavar F, Wong KC, Mitchell KA. Titanium boron nitride films grown by ion beam assisted deposition: chemical and optical characterization. Surf Coat Technol. 2004;183(2-3):369-377.
34. Lousinian S, Kalfagiannis N, Logothetidis S. Albumin and fibrinogen adsorption on boron nitride and carbon-based thin films. Mater Sci EngB. 2008;152(1-3):12-15.
35. Vallance P, Chan N. Endothelial function and nitric oxide: clinical relevance. Heart. 2001;85(3):342-350.
36. Usui Y, Aoki K, Narita N, et al. Carbon nanotubes with high bonetissue compatibility and bone-formation acceleration effects. Small. 2008;4(2):240-246.
37. Kim JY, Khang D, Lee JE, Webster TJ. Decreased macrophage density on carbon nanotube patterns on polycarbonate urethane. JBiomed Mater Res A. 2009;8(2):419-126.
38. Muller J, Huaux F, Fonseca A, et al. Structural defects play a major role in the acute lung toxicity of multiwall carbon nanotubes: toxicological aspects. Chem Res Toxicol. 2008;21(9):1698-1705.
39. Linneweber J, Dohmen PM, Kertzscher U, Affeld K, Nosé Y, Konertz W. The effect of surface roughness on activation of the coagulation system and platelet adhesion in rotary blood pumps. Artif Organs. 2007;31(5):345-351.
40. Xu LC, Siedlecki CA. Effects of surface wettability and contact time on protein adhesion to biomaterial surfaces. Biomaterials. 2007; 28(22):3273-3283.
41. Tulloch AW, Chun Y, Levi DS, et al. Super hydrophilic thin film nitinol demonstrates reduced platelet adhesion compared with commercially available endograft materials. J Surg Res. 2011;171(1):317-322.
42. Kuznetsova TG, Starodubtseva MN, Yegorenkov NI, Chizhik SA, Zhdanov RI. Atomic force microscopy probing of cell elasticity. Micron. 2007;38(8):824-833.
43. Fritz M, Radmacher M, Gaub HE. Granula motion and membrane spreading during activation of human platelets imaged by atomic force microscopy. Biophys J. 1994;66(5):1328-1334.
44. Radmacher M, Fritz M, Kacher M, Cleveland P, Hansma, K. Measuring the viscoelastic properties of human platelets with the atomic force microscope. Biophys J. 1996;70(1):556-567.
45. Henriques SS, Sandmann R, Strate A, Köster S. Force field evolution during human blood platelet activation. J Cell Sci. 2012. Epub May 11.